• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues.在酶谱法方案中对基质和 pH 值进行操作,可以有选择性地区分细胞和组织中组织蛋白酶 K、L、S 和 V 的活性。
Arch Biochem Biophys. 2011 Dec 1;516(1):52-7. doi: 10.1016/j.abb.2011.09.009. Epub 2011 Sep 29.
2
Multiplex Cathepsin Zymography to Detect Amounts of Active Cathepsins K, L, S, and V.多重组织蛋白酶酶谱法检测组织蛋白酶K、L、S和V的活性量
Methods Mol Biol. 2017;1626:239-252. doi: 10.1007/978-1-4939-7111-4_23.
3
Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages.正常及组织蛋白酶K缺陷型人类巨噬细胞中弹性蛋白分解半胱氨酸蛋白酶活性的调节
J Exp Med. 2000 Sep 18;192(6):789-99. doi: 10.1084/jem.192.6.789.
4
Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.高侵袭性黑色素瘤细胞中细胞外活性组织蛋白酶B和L的鉴定与区分
Anal Biochem. 2006 Jun 1;353(1):57-62. doi: 10.1016/j.ab.2006.01.037. Epub 2006 Feb 9.
5
Multiplex zymography captures stage-specific activity profiles of cathepsins K, L, and S in human breast, lung, and cervical cancer.多重酶谱法可捕捉到组织蛋白酶 K、L 和 S 在人乳腺癌、肺癌和宫颈癌中的特定阶段的活性谱。
J Transl Med. 2011 Jul 14;9:109. doi: 10.1186/1479-5876-9-109.
6
Tumor necrosis factor alpha stimulates cathepsin K and V activity via juxtacrine monocyte-endothelial cell signaling and JNK activation.肿瘤坏死因子-α通过旁分泌单核细胞-内皮细胞信号和 JNK 激活刺激组织蛋白酶 K 和 V 的活性。
Mol Cell Biochem. 2012 Aug;367(1-2):65-72. doi: 10.1007/s11010-012-1320-0. Epub 2012 May 5.
7
Improvement of cathepsin S detection using a designed FRET peptide based on putative natural substrates.基于假定天然底物设计的 FRET 肽提高组织蛋白酶 S 的检测。
Peptides. 2010 Apr;31(4):562-7. doi: 10.1016/j.peptides.2009.12.027. Epub 2010 Jan 5.
8
Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits.兔重组破骨细胞特异性组织蛋白酶K的底物特异性
Biol Pharm Bull. 1996 Aug;19(8):1026-31. doi: 10.1248/bpb.19.1026.
9
Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages.组织蛋白酶V,一种在活化巨噬细胞中表达的新型强效弹性蛋白酶活性物质。
J Biol Chem. 2004 Aug 27;279(35):36761-70. doi: 10.1074/jbc.M403986200. Epub 2004 Jun 10.
10
Expression of elastolytic cathepsins in human skin and their involvement in age-dependent elastin degradation.弹性蛋白酶cathepsins 在人体皮肤中的表达及其在年龄相关性弹力蛋白降解中的作用。
Biochim Biophys Acta Gen Subj. 2020 May;1864(5):129544. doi: 10.1016/j.bbagen.2020.129544. Epub 2020 Jan 30.

引用本文的文献

1
Cathepsins in cellular entry of human pathogenic viruses.组织蛋白酶在人类致病病毒的细胞进入过程中的作用
J Virol. 2025 Apr 15;99(4):e0164224. doi: 10.1128/jvi.01642-24. Epub 2025 Mar 26.
2
Mutations in α-synuclein, TDP-43 and tau prolong protein half-life through diminished degradation by lysosomal proteases.α-突触核蛋白、TDP-43 和 tau 的突变通过减少溶酶体蛋白酶的降解来延长蛋白质半衰期。
Mol Neurodegener. 2023 May 2;18(1):29. doi: 10.1186/s13024-023-00621-8.
3
Sickle cell disease promotes sex-dependent pathological bone loss through enhanced cathepsin proteolytic activity in mice.镰状细胞病通过增强小鼠组织蛋白酶的蛋白水解活性促进性别依赖性病理性骨丢失。
Blood Adv. 2022 Mar 8;6(5):1381-1393. doi: 10.1182/bloodadvances.2021004615.
4
Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.SARS-CoV-2 刺突蛋白上的多个位点易受组织蛋白酶 B、K、L、S 和 V 的蛋白水解作用影响。
Protein Sci. 2021 Jun;30(6):1131-1143. doi: 10.1002/pro.4073. Epub 2021 Apr 15.
5
Cysteine cathepsins are altered by flow within an engineered microvascular niche.半胱氨酸组织蛋白酶在工程化微血管微环境中会因流动而发生改变。
APL Bioeng. 2020 Nov 4;4(4):046102. doi: 10.1063/5.0023342. eCollection 2020 Dec.
6
Tumor cell-organized fibronectin maintenance of a dormant breast cancer population.肿瘤细胞组织化纤维连接蛋白维持休眠乳腺癌群体。
Sci Adv. 2020 Mar 11;6(11):eaaz4157. doi: 10.1126/sciadv.aaz4157. eCollection 2020 Mar.
7
Sickle Cell Anemia Mediates Carotid Artery Expansive Remodeling That Can Be Prevented by Inhibition of JNK (c-Jun N-Terminal Kinase).镰状细胞贫血介导颈动脉扩张性重塑,可通过抑制 JNK(c-Jun N 端激酶)来预防。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1220-1230. doi: 10.1161/ATVBAHA.120.314045. Epub 2020 Mar 12.
8
Reassessing enzyme kinetics: Considering protease-as-substrate interactions in proteolytic networks.重新评估酶动力学:考虑蛋白水解网络中蛋白酶-底物相互作用。
Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):3307-3318. doi: 10.1073/pnas.1912207117. Epub 2020 Jan 24.
9
Dynamic Model of Protease State and Inhibitor Trafficking to Predict Protease Activity in Breast Cancer Cells.蛋白酶状态与抑制剂转运的动态模型以预测乳腺癌细胞中的蛋白酶活性
Cell Mol Bioeng. 2019 Jun 19;12(4):275-288. doi: 10.1007/s12195-019-00580-5. eCollection 2019 Aug.
10
CCAAT-displacement protein/cut homeobox transcription factor (CUX1) represses estrogen receptor-alpha (ER-α) in triple-negative breast cancer cells and can be antagonized by muscadine grape skin extract (MSKE).CCAAT 位移蛋白/切割同源盒转录因子 (CUX1) 在三阴性乳腺癌细胞中抑制雌激素受体-α (ER-α),并可被麝香葡萄皮提取物 (MSKE) 拮抗。
PLoS One. 2019 Apr 9;14(4):e0214844. doi: 10.1371/journal.pone.0214844. eCollection 2019.

本文引用的文献

1
Multiplex zymography captures stage-specific activity profiles of cathepsins K, L, and S in human breast, lung, and cervical cancer.多重酶谱法可捕捉到组织蛋白酶 K、L 和 S 在人乳腺癌、肺癌和宫颈癌中的特定阶段的活性谱。
J Transl Med. 2011 Jul 14;9:109. doi: 10.1186/1479-5876-9-109.
2
Specialized roles for cysteine cathepsins in health and disease.半胱氨酸蛋白酶在健康和疾病中的特异性作用。
J Clin Invest. 2010 Oct;120(10):3421-31. doi: 10.1172/JCI42918. Epub 2010 Oct 1.
3
Conformational flexibility and allosteric regulation of cathepsin K.组织蛋白酶 K 的构象灵活性和变构调节。
Biochem J. 2010 Jul 15;429(2):379-89. doi: 10.1042/BJ20100337.
4
Cathepsins and cystatin C in atherosclerosis and obesity.组织蛋白酶和胱抑素 C 在动脉粥样硬化和肥胖中的作用。
Biochimie. 2010 Nov;92(11):1580-6. doi: 10.1016/j.biochi.2010.04.011. Epub 2010 Apr 24.
5
Pharmacological inhibition of cathepsin S decreases atherosclerotic lesions in Apoe-/- mice.组织蛋白酶 S 的药理学抑制可减少 Apoe-/- 小鼠的动脉粥样硬化病变。
J Cardiovasc Pharmacol. 2010 Jul;56(1):98-105. doi: 10.1097/FJC.0b013e3181e23e10.
6
Detection of femtomole quantities of mature cathepsin K with zymography.用酶谱法检测成熟组织蛋白酶 K 的皮摩尔量。
Anal Biochem. 2010 Jun 1;401(1):91-8. doi: 10.1016/j.ab.2010.02.035. Epub 2010 Mar 3.
7
Comparative assessment of substrates and activity based probes as tools for non-invasive optical imaging of cysteine protease activity.基于底物和活性探针的半胱氨酸蛋白酶活性非侵入性光学成像工具的比较评估。
PLoS One. 2009 Jul 28;4(7):e6374. doi: 10.1371/journal.pone.0006374.
8
Cathepsin K inhibitors as treatment of bone metastasis.组织蛋白酶K抑制剂用于治疗骨转移
Curr Opin Support Palliat Care. 2008 Sep;2(3):218-22. doi: 10.1097/SPC.0b013e32830baea9.
9
Biochemical properties and regulation of cathepsin K activity.组织蛋白酶K活性的生化特性与调控
Biochimie. 2008 Feb;90(2):208-26. doi: 10.1016/j.biochi.2007.08.011. Epub 2007 Sep 2.
10
Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes.使用基于活性的荧光猝灭探针进行半胱氨酸蛋白酶活性的无创光学成像。
Nat Chem Biol. 2007 Oct;3(10):668-77. doi: 10.1038/nchembio.2007.26. Epub 2007 Sep 9.

在酶谱法方案中对基质和 pH 值进行操作,可以有选择性地区分细胞和组织中组织蛋白酶 K、L、S 和 V 的活性。

Manipulating substrate and pH in zymography protocols selectively distinguishes cathepsins K, L, S, and V activity in cells and tissues.

机构信息

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, 30332, USA.

出版信息

Arch Biochem Biophys. 2011 Dec 1;516(1):52-7. doi: 10.1016/j.abb.2011.09.009. Epub 2011 Sep 29.

DOI:10.1016/j.abb.2011.09.009
PMID:21982919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3221864/
Abstract

Cathepsins K, L, S, and V are cysteine proteases that have been implicated in tissue-destructive diseases such as atherosclerosis, tumor metastasis, and osteoporosis. Among these four cathepsins are the most powerful human collagenases and elastases, and they share 60% sequence homology. Proper quantification of mature, active cathepsins has been confounded by inhibitor and reporter substrate cross-reactivity, but is necessary to develop properly dosed therapeutic applications. Here, we detail a method of multiplex cathepsin zymography to detect and distinguish the activity of mature cathepsins K, L, S, and V by exploiting differences in individual cathepsin substrate preferences, pH effects, and electrophoretic mobility under non-reducing conditions. Specific identification of cathepsins K, L, S, and V in one cell/tissue extract was obtained with cathepsin K (37 kDa), V (35 kDa), S (25 kDa), and L (20 kDa) under non-reducing conditions. Cathepsin K activity disappeared and V remained when incubated at pH 4 instead of 6. Application of this antibody free, species independent, and medium-throughput method was demonstrated with primary human monocyte-derived macrophages and osteoclasts, endothelial cells stimulated with inflammatory cytokines, and normal and cancer lung tissues, which identified elevated cathepsin V in lung cancer.

摘要

组织破坏性疾病,如动脉粥样硬化、肿瘤转移和骨质疏松症,与组织破坏性疾病有关的组织蛋白酶 K、L、S 和 V 是半胱氨酸蛋白酶。在这四种组织蛋白酶中,它们是最有效的人类胶原酶和弹性蛋白酶,并且它们具有 60%的序列同源性。成熟、活性组织蛋白酶的适当定量受到抑制剂和报告底物交叉反应性的困扰,但开发适当剂量的治疗应用是必要的。在这里,我们详细介绍了一种多重组织蛋白酶酶谱法,通过利用单个组织蛋白酶底物偏好、pH 效应和非还原条件下的电泳迁移率的差异,来检测和区分成熟组织蛋白酶 K、L、S 和 V 的活性。在非还原条件下,用组织蛋白酶 K(37 kDa)、V(35 kDa)、S(25 kDa)和 L(20 kDa)特异性识别一种细胞/组织提取物中的组织蛋白酶 K、L、S 和 V。在 pH 4 而不是 6 孵育时,组织蛋白酶 K 的活性消失而 V 保持。该抗体独立、种间独立且高通量的方法已应用于原代人单核细胞衍生的巨噬细胞和破骨细胞、用炎性细胞因子刺激的内皮细胞以及正常和癌症肺组织,该方法鉴定出肺癌中组织蛋白酶 V 的升高。